• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    4.61 Up 0.01(0.22%) Feb 9, 4:00PM EST
    Prev Close:4.60
    Open:4.57
    Bid:4.00 x 1500
    Ask:5.88 x 200
    1y Target Est:7.88
    Beta:1.64489
    Next Earnings Date:23-Feb-16ARIA Earnings announcement
    Day's Range:4.48 - 4.84
    52wk Range:4.48 - 10.07
    Volume:2,672,159
    Avg Vol (3m):3,454,390
    Market Cap:872.64M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 0.22%872.64M
    PFEUp 1.89%179.65B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.24
    Quarterly EPS Est (Dec-15) :-0.31
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback